James C. Byrd
Impact in
- Immunology top 2%
- Galectins and Cancer Biology
- Molecular Biology top 2%
- Glycosylation and Glycoproteins Research
- Signaling Pathways in Disease
Papers in
-
- Glycosylation and Glycoproteins Research 40
- Metabolism, Diabetes, and Cancer 5
- Immunology 24
- Galectins and Cancer Biology 24
- Co-authors
- Robert S. Bresalier (30 shared papers)Richard G. MacDonald (12 shared papers)James R. Gum (6 shared papers)James W. Hicks (4 shared papers)Young S. Kim (9 shared papers)Avraham Raz (7 shared papers)Bader Siddiki (5 shared papers)Gordon Schectman (2 shared papers)
- Journals
- Journal of Biological Chemistry (14 papers)Gastroenterology (14 papers)Cancer (7 papers)American Journal of Public Health (6 papers)Journal of General Internal Medicine (4 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
James C. Byrd
113 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 165
- Immunology 1.4k
- Molecular Biology 3.3k
- Cell Biology 457
- Nutrition and Dietetics 412
- Organic Chemistry 806
Countries citing papers authored by James C. Byrd
This map shows the geographic impact of James C. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Byrd more than expected).
Fields of papers citing papers by James C. Byrd
This network shows the impact of papers produced by James C. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Byrd. The network helps show where James C. Byrd may publish in the future.
Co-authors
The 25 scholars most cited alongside James C. Byrd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 417 | |
| 2 | 1990 | 326 | |
| 3 | 1993 | 326 | |
| 4 | 1989 | 275 | |
| 5 | 1989 | 237 | |
| 6 | 2000 | 216 | |
| 7 | 1991 | 162 | |
| 8 | 2004 | 161 | |
| 9 | 1998 | 155 | |
| 10 | 1997 | 146 | |
| 11 | 1982 | 146 | |
| 12 | 1987 | 139 | |
| 13 | 1989 | 130 | |
| 14 | 1994 | 130 | |
| 15 | 2000 | 109 | |
| 16 | 2006 | 104 | |
| 17 | 2000 | 99 | |
| 18 | 2000 | 96 | |
| 19 | Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. | 1996 | 91 |
| 20 | 2011 | 77 |
About James C. Byrd
James C. Byrd is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Surgery and Oncology, having authored 113 papers that have together received 6.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (40 papers), Galectins and Cancer Biology (24 papers), Carbohydrate Chemistry and Synthesis (13 papers), Microbial Metabolites in Food Biotechnology (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Cancer Cells and Metastasis (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Immunology (1.4k citations), Molecular Biology (3.3k citations), Cell Biology (457 citations), Nutrition and Dietetics (412 citations) and Organic Chemistry (806 citations). James C. Byrd has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Robert S. Bresalier, Richard G. MacDonald, James R. Gum, James W. Hicks, Young S. Kim, Avraham Raz, Bader Siddiki, Gordon Schectman, Harvey W. Gruchow and Cathy D. Meade. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology, Cancer, American Journal of Public Health and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.